PharmacyCodes



Clormezanone [DCIT] en es it fr

Clormezanone [DCIT] Brand names, Clormezanone [DCIT] Analogs

Clormezanone [DCIT] Brand Names Mixture

  • No information avaliable

Clormezanone [DCIT] Chemical_Formula

C11H12ClNO3S

Clormezanone [DCIT] RX_link

No information avaliable

Clormezanone [DCIT] fda sheet

Clormezanone [DCIT] msds (material safety sheet)

Clormezanone [DCIT] Synthesis Reference

No information avaliable

Clormezanone [DCIT] Molecular Weight

273.737 g/mol

Clormezanone [DCIT] Melting Point

116.2 oC

Clormezanone [DCIT] H2O Solubility

2500 mg/L (hardly soluble)

Clormezanone [DCIT] State

Solid

Clormezanone [DCIT] LogP

1.208

Clormezanone [DCIT] Dosage Forms

No information avaliable

Clormezanone [DCIT] Indication

Used in the management of anxiety and in the treatment of muscle spasm.

Clormezanone [DCIT] Pharmacology

Chlormezanone is a non-benzodiazepine muscle relaxant. It was discontinued worldwide in 1996 by its manufacturer due to confirmed serious and rare cutaneous reactions (toxic epidermal necrolysis).

Clormezanone [DCIT] Absorption

No information avaliable

Clormezanone [DCIT] side effects and Toxicity

Symptoms of overdose include drowsiness, weakness, nausea, dizziness, abdominal pain, cerebral oedema and renal tubular necrosis, hyperglycaemia and hypoglycaemia, liver damage, encephalopathy, coma and death.

Clormezanone [DCIT] Patient Information

No information avaliable

Clormezanone [DCIT] Organisms Affected

Humans and other mammals